REG - Eco Animal Health Gp - Total Voting Rights

ECO Animal HealthAnnouncement

30/04/2021 14:05

RNS Number : 2742X
  
Eco Animal Health Group PLC
  
30 April 2021
  
 

30 April 2021
 
 
ECO Animal Health Group PLC
 
Total Voting Rights and Share Capital
 
 
ECO Animal Health Group PLC (the "Company") announces that, as at 30 April 2021, its issued share capital consists of 67,704,416 ordinary shares of 5 pence each with voting rights ('Ordinary Shares'). No Ordinary Shares are currently held in treasury and the voting rights of all the Ordinary Shares are identical.
 
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.
 
 
For further information, please contact:
 



 
ECO Animal Health Group plc
Marc Loomes (CEO)
Christopher Wilks (CFO)
 




020 8447 8899
 




IFC Advisory
Graham Herring
Zach Cohen
 


020 3934 6630
 




N+1 Singer (Nominated Adviser & Joint Broker)
Mark Taylor
Iqra Amin
 


020 7496 3000




Peel Hunt LLP (Joint Broker)
James Steel
Dr Christopher Golden


020 7418 8900



 
 
 
 
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development for new products, particularly vaccines, and seeking to in-license new products.
 
 
 
 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
TVREAALEDLSFEFA